191 related articles for article (PubMed ID: 21434863)
1. Non-alcoholic fatty liver disease in HIV infection associated with altered hepatic fatty acid composition.
Arendt BM; Mohammed SS; Ma DW; Aghdassi E; Salit IE; Wong DK; Guindi M; Sherman M; Heathcote EJ; Allard JP
Curr HIV Res; 2011 Mar; 9(2):128-35. PubMed ID: 21434863
[TBL] [Abstract][Full Text] [Related]
2. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.
Allard JP; Aghdassi E; Mohammed S; Raman M; Avand G; Arendt BM; Jalali P; Kandasamy T; Prayitno N; Sherman M; Guindi M; Ma DW; Heathcote JE
J Hepatol; 2008 Feb; 48(2):300-7. PubMed ID: 18086506
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
Walle P; Takkunen M; Männistö V; Vaittinen M; Lankinen M; Kärjä V; Käkelä P; Ågren J; Tiainen M; Schwab U; Kuusisto J; Laakso M; Pihlajamäki J
Metabolism; 2016 May; 65(5):655-666. PubMed ID: 27085774
[TBL] [Abstract][Full Text] [Related]
4. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids.
Arendt BM; Comelli EM; Ma DW; Lou W; Teterina A; Kim T; Fung SK; Wong DK; McGilvray I; Fischer SE; Allard JP
Hepatology; 2015 May; 61(5):1565-78. PubMed ID: 25581263
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Dietary Fatty Acid Intake with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in People with HIV.
de Almeida CF; da Silva PS; Cardoso CSA; Moreira NG; Antunes JC; de Andrade MM; Silva J; Araujo MC; Peres WAF; do Brasil PEAA; Moreira RI; Cardoso SW; Veloso VG; Grinsztejn B; de Brito PD; Perazzo H
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684463
[TBL] [Abstract][Full Text] [Related]
6. Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects.
Ma DW; Arendt BM; Hillyer LM; Fung SK; McGilvray I; Guindi M; Allard JP
Nutr Diabetes; 2016 Jul; 6(7):e220. PubMed ID: 27428872
[TBL] [Abstract][Full Text] [Related]
7. Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease.
Elizondo A; Araya J; Rodrigo R; Signorini C; Sgherri C; Comporti M; Poniachik J; Videla LA
Biol Res; 2008; 41(1):59-68. PubMed ID: 18769764
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: impact of omega-3 fatty acids.
Spahis S; Alvarez F; Ahmed N; Dubois J; Jalbout R; Paganelli M; Grzywacz K; Delvin E; Peretti N; Levy E
J Nutr Biochem; 2018 Aug; 58():28-36. PubMed ID: 29864682
[TBL] [Abstract][Full Text] [Related]
9. Hepatic fatty acid composition differs between chronic hepatitis C patients with and without steatosis.
Arendt BM; Mohammed SS; Aghdassi E; Prayitno NR; Ma DW; Nguyen A; Guindi M; Sherman M; Heathcote EJ; Allard JP
J Nutr; 2009 Apr; 139(4):691-5. PubMed ID: 19211827
[TBL] [Abstract][Full Text] [Related]
10. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.
Araya J; Rodrigo R; Videla LA; Thielemann L; Orellana M; Pettinelli P; Poniachik J
Clin Sci (Lond); 2004 Jun; 106(6):635-43. PubMed ID: 14720121
[TBL] [Abstract][Full Text] [Related]
11. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls.
Da Silva HE; Arendt BM; Noureldin SA; Therapondos G; Guindi M; Allard JP
J Acad Nutr Diet; 2014 Aug; 114(8):1181-94. PubMed ID: 24631112
[TBL] [Abstract][Full Text] [Related]
12. Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis.
Malínská H; Oliyarnyk O; Hubová M; Zídek V; Landa V; Simáková M; Mlejnek P; Kazdová L; Kurtz TW; Pravenec M
Mol Cell Biochem; 2010 Feb; 335(1-2):119-25. PubMed ID: 19756959
[TBL] [Abstract][Full Text] [Related]
13. Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease.
Arendt BM; Teterina A; Pettinelli P; Comelli EM; Ma DWL; Fung SK; McGilvray ID; Fischer SE; Allard JP
Nutrition; 2019 Jun; 62():100-107. PubMed ID: 30870804
[TBL] [Abstract][Full Text] [Related]
14. Influence of the nutritional status and oxidative stress in the desaturation and elongation of n-3 and n-6 polyunsaturated fatty acids: Impact on non-alcoholic fatty liver disease.
Videla LA; Hernandez-Rodas MC; Metherel AH; Valenzuela R
Prostaglandins Leukot Essent Fatty Acids; 2022 Jun; 181():102441. PubMed ID: 35537354
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine.
Arendt BM; Ma DW; Simons B; Noureldin SA; Therapondos G; Guindi M; Sherman M; Allard JP
Appl Physiol Nutr Metab; 2013 Mar; 38(3):334-40. PubMed ID: 23537027
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.
Kelley NS
Metab Syndr Relat Disord; 2016 Nov; 14(9):417-430. PubMed ID: 27710160
[TBL] [Abstract][Full Text] [Related]
17. Plasma fatty acid composition in French-Canadian children with non-alcoholic fatty liver disease: Effect of n-3 PUFA supplementation.
Spahis S; Alvarez F; Dubois J; Ahmed N; Peretti N; Levy E
Prostaglandins Leukot Essent Fatty Acids; 2015 Aug; 99():25-34. PubMed ID: 26066299
[TBL] [Abstract][Full Text] [Related]
18. Impairment of reproductive function in a male rat model of non-alcoholic fatty liver disease and beneficial effect of N-3 fatty acid supplementation.
Li Y; Liu L; Wang B; Xiong J; Li Q; Wang J; Chen D
Toxicol Lett; 2013 Oct; 222(2):224-32. PubMed ID: 23747427
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid composition and development of hepatic lipidosis during food deprivation--mustelids as a potential animal model for liver steatosis.
Nieminen P; Mustonen AM; Kärjä V; Asikainen J; Rouvinen-Watt K
Exp Biol Med (Maywood); 2009 Mar; 234(3):278-86. PubMed ID: 19144866
[TBL] [Abstract][Full Text] [Related]
20. Associations of serum n-3 and n-6 polyunsaturated fatty acids with prevalence and incidence of nonalcoholic fatty liver disease.
Mäkelä TNK; Tuomainen TP; Hantunen S; Virtanen JK
Am J Clin Nutr; 2022 Sep; 116(3):759-770. PubMed ID: 35648467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
